Loading...

GNNT

GNT

GENENTA SCIENCE SPA

(GNTA)

2025 6-K

Major Acquisition Planned

27 Mar '26

Name Change Revoked

23 Mar '26

Corporate Changes Announced

27 Jan '26

Cash Forecast Update

27 Jan '26

Shareholder Meeting Outcomes

3 Nov '25

Registered Direct Offering

28 Oct '25

Shareholders' Meeting

27 Oct '25

Financial Results Report

10 Oct '25

Management Change

3 Oct '25

Shareholder Meeting Notice

10 Sep '25

Manufacturing Update

1 Aug '25

Convertible Bond Agreement

19 Mar '25

Financing Announcement

19 Mar '25

Service Agreement Update

30 Dec '24

Sales Agreement Update

20 Dec '24

LOI Extension

13 Dec '24

AGC Partnership Intent

14 Nov '24

Financial Results Report

29 Oct '24

Board Changes Announcement

3 May '24

Sales Agreement Filed

26 Apr '24

Board Changes

8 Apr '24

Shareholders Meeting Notice

2 Apr '24

External Links:

SEC

On March 19, 2025, Genenta Science S.p.A. announced €20 million ($20.9 million) financing through a mandatory convertible bond issued to ENEA Tech and Biomedical to support the development of their Temferon™ cell therapy.

AI Assistant

GENENTA SCIENCE SPA

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.